VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 89 filers reported holding VERONA PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $113,414,715 | -24.5% | 6,957,958 | -2.1% | 0.01% | -23.1% |
Q2 2023 | $150,300,539 | -18.1% | 7,109,770 | -22.2% | 0.01% | +62.5% |
Q1 2023 | $183,417,910 | +222.9% | 9,134,358 | +320.1% | 0.01% | +33.3% |
Q4 2022 | $56,810,435 | +1244.6% | 2,174,146 | +425.9% | 0.01% | – |
Q3 2022 | $4,225,000 | – | 413,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,111,112 | $11,356,000 | 29.98% |
Aisling Capital Management LP | 1,332,485 | $13,618,000 | 9.04% |
Abingworth LLP | 2,457,500 | $25,091,000 | 8.58% |
Fairmount Funds Management LLC | 2,678,982 | $27,379,000 | 4.81% |
Vivo Capital, LLC | 4,249,918 | $43,434,000 | 4.80% |
NEA Management Company, LLC | 5,584,753 | $57,076,000 | 2.85% |
Octagon Capital Advisors LP | 1,324,868 | $13,540,000 | 2.34% |
Samsara BioCapital, LLC | 938,890 | $9,595,000 | 2.24% |
ACT CAPITAL MANAGEMENT, LLC | 143,500 | $1,467,000 | 2.02% |
Frazier Life Sciences Management, L.P. | 2,099,541 | $21,457,000 | 1.65% |